(Q40828806)

24 September 2017

1 reference

title

DNA immunization: present and future (English)

1 reference

24 September 2017

1

Babiuk LA

1 reference

24 September 2017

Lewis J

2

1 reference

24 September 2017

van den Hurk S

series ordinal

3

1 reference

24 September 2017

Braun R

series ordinal

4

1 reference

24 September 2017

language of work or name

1 reference

1 January 1999

1 reference

Advances in veterinary medicine

24 September 2017

published in

1 reference

24 September 2017

volume

41

1 reference

24 September 2017

page(s)

163-179

1 reference

The role of antibody concentration and avidity in antiviral protection.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

The skin immune system: progress in cutaneous biology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Plasmid vectors as anti-viral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Accessories for naked DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Polynucleotide vaccines in animals: enhancing and modulating responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Activation of mouse complement by monoclonal mouse antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Potential DNA vaccine integration into host cell genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

1 reference

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Aerosol gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3519%2899%2980015-9

7 January 2021

10.1016/S0065-3519(99)80015-9

Identifiers

DOI

0 references

1 reference